Literature DB >> 7872585

Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis.

M van Buren1, R J Hené, L F Verdonck, F J Verzijlbergen, H M Lokhorst.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7872585     DOI: 10.7326/0003-4819-122-7-199504010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Secondary and Infiltrative Cardiomyopathies.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

2.  Restrictive Cardiomyopathy.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

3.  Amyloidosis 2008 BMT Tandem Meetings (February 13-17, San Diego).

Authors:  Angela Dispenzieri; Giampaolo Merlini; Raymond L Comenzo
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

4.  [Systemic Al-amyloidosis. Clinical course and limits of melphalan therapy].

Authors:  G R Hetzel; P Heering; B Grabensee
Journal:  Med Klin (Munich)       Date:  1999-10-15

5.  Cardiac Amyloidosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.